Iradimed (IRMD) Net Cash Flow Growth (3y) (2016 - 2026)
Iradimed (IRMD) Net Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.40 Bn | 176.11 Bn | 6.27 Bn | -32.51% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | -87.87% |
| 3 | Medtronic | 108.35 Bn | 99.13 Bn | 6.41 Bn | 31.32% |
| 4 | Boston Scientific | 68.71 Bn | 67.25 Bn | 3.61 Bn | -11.49% |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | -87.88% |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 129.29% |
| 7 | GE HealthCare Technologies | 28.04 Bn | 25.76 Bn | 1.98 Bn | -65.12% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | -48.90% |
| 10 | Iradimed | 1.22 Bn | 1.16 Bn | 16.81 Mn | 32.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.83% |
| Dec 31, 2025 | -62.18% |
| Sep 30, 2025 | 0.92% |
| Jun 30, 2025 | 15.91% |
| Mar 31, 2025 | 45.18% |
| Dec 31, 2024 | -47.93% |
| Sep 30, 2024 | -0.27% |
| Jun 30, 2024 | -7.87% |
| Mar 31, 2024 | -102.67% |
| Dec 31, 2023 | 6.20% |
| Sep 30, 2023 | -23.89% |
| Jun 30, 2023 | 54.78% |
| Mar 31, 2023 | -147.45% |
| Dec 31, 2022 | -21.22% |
| Sep 30, 2022 | -17.94% |
| Jun 30, 2022 | -14.50% |
| Mar 31, 2022 | -107.80% |
| Dec 31, 2021 | -5.72% |
| Sep 30, 2021 | 10.69% |
| Jun 30, 2021 | 52.13% |